Chilean GeneproDX is ready to go global with its patented ThyroidPrint®

Chilean biotech GeneproDX can substantially increase the prediction accuracy of detecting thyroid cancer and dramatically reduce the need for surgery which is currently used to confirm cancer diagnosis in indeterminate nodules.

______________________________________________________________